Chesapeake Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-40
Closed -$2.69K – 390
2026
Q2
$2.69K Buy
+40
New +$2.66K ﹤0.01% 311
2025
Q2
– Sell
-10
Closed -$682 – 382
2025
Q1
$682 Buy
10
+5
+100% +$408 ﹤0.01% 409
2024
Q4
$388 Buy
+5
New +$370 ﹤0.01% 421

Other funds holding DXCM

Chesapeake Asset Management's DXCM Position: Q3 2026 in Review

Chesapeake Asset Management sold out of DexCom (DXCM) in Q3 2026, closing a stake of 40 shares — an estimated $2.69K sold.

Chesapeake Asset Management first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $2.69K in Q2 2026. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Chesapeake Asset Management reported no remaining DexCom position as of Q3 2026 after selling out during the quarter.
  • Chesapeake Asset Management sold 40 DexCom shares in Q3 2026, an estimated $2.69K.
  • Chesapeake Asset Management first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Chesapeake Asset Management's DexCom position peaked at $2.69K in Q2 2026.
  • 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Chesapeake Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.